Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
The Heart-Lung Dilemma in COPD: A Tale of Two Cities.

Archivos de bronconeumologia

López-Campos JL, Carrasco Hernández L, Quintana Gallego E.
PMID: 30471917
Arch Bronconeumol (Engl Ed). 2019 Apr;55(4):185-186. doi: 10.1016/j.arbres.2018.10.006. Epub 2018 Nov 22.

No abstract available.

Cite
López-Campos JL, Carrasco Hernández L, Quintana Gallego E. El dilema entre el pulmón y el corazón en EPOC: historia de dos ciudades. The Heart-Lung Dilemma in COPD: A Tale of Two Cities. Arch Bronconeumol (Engl Ed). 2018;55(4):185-186doi: 10.1016/j.arbres.2018.10.006.
López-Campos, J. L., Carrasco Hernández, L., & Quintana Gallego, E. (2019). El dilema entre el pulmón y el corazón en EPOC: historia de dos ciudades. The Heart-Lung Dilemma in COPD: A Tale of Two Cities. Archivos de bronconeumologia, 55(4), 185-186. https://doi.org/10.1016/j.arbres.2018.10.006
López-Campos, José Luis, et al. "El dilema entre el pulmón y el corazón en EPOC: historia de dos ciudades." The Heart-Lung Dilemma in COPD: A Tale of Two Cities. Archivos de bronconeumologia vol. 55,4 (2019): 185-186. doi: https://doi.org/10.1016/j.arbres.2018.10.006
López-Campos JL, Carrasco Hernández L, Quintana Gallego E. El dilema entre el pulmón y el corazón en EPOC: historia de dos ciudades. The Heart-Lung Dilemma in COPD: A Tale of Two Cities. Arch Bronconeumol (Engl Ed). 2019 Apr;55(4):185-186. doi: 10.1016/j.arbres.2018.10.006. Epub 2018 Nov 22. Spanish. PMID: 30471917.
Copy Download .nbib Format: NLM
Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine.

Biomedicines

Carrasco-Hernández L, Quintana-Gallego E, Calero C, Reinoso-Arija R, Ruiz-Duque B, López-Campos JL.
PMID: 34680554
Biomedicines. 2021 Oct 10;9(10). doi: 10.3390/biomedicines9101437.

In recent years, numerous pathways were explored in the pathogenesis of COPD in the quest for new potential therapeutic targets for more personalised medical care. In this context, the study of the cystic fibrosis transmembrane conductance regulator (CFTR) began...

Cite
Carrasco-Hernández L, Quintana-Gallego E, Calero C, et al. Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine. Biomedicines. 2021;9(10)doi: 10.3390/biomedicines9101437.
Carrasco-Hernández, L., Quintana-Gallego, E., Calero, C., Reinoso-Arija, R., Ruiz-Duque, B., & López-Campos, J. L. (2021). Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine. Biomedicines, 9(10), . https://doi.org/10.3390/biomedicines9101437
Carrasco-Hernández, Laura, et al. "Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine." Biomedicines vol. 9,10 (2021). doi: https://doi.org/10.3390/biomedicines9101437
Carrasco-Hernández L, Quintana-Gallego E, Calero C, Reinoso-Arija R, Ruiz-Duque B, López-Campos JL. Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine. Biomedicines. 2021 Oct 10;9(10). doi: 10.3390/biomedicines9101437. PMID: 34680554; PMCID: PMC8533244.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries